Who Exports Immunoglobulin from India — 197 Suppliers Behind a $180.0M Market
India's immunoglobulin export market is supplied by 197 active exporters who collectively shipped $180.0M across 1,841 shipments. RELIANCE LIFE SCIENCES PRIVATE LIMITED leads with a 47.0% market share, followed by BHARAT SERUMS AND VACCINES LIMITED and RELIANCE LIFE SCIENCES PVT LTD. The top 5 suppliers together control 75.8% of total export value, reflecting a concentrated market structure.
Top Immunoglobulin Exporters from India — Ranked by Export Value
RELIANCE LIFE SCIENCES PRIVATE LIMITED is the leading immunoglobulin exporter from India, holding a 47.0% share of the $180.0M market across 1,841 shipments from 197 exporters. The top 5 suppliers — RELIANCE LIFE SCIENCES PRIVATE LIMITED, BHARAT SERUMS AND VACCINES LIMITED, RELIANCE LIFE SCIENCES PVT LTD, LAZERHEAD LIFESCIENCES PRIVATE LIMITED, VITANE PHARMACEUTICALS PRIVATE LIMITED — collectively control 75.8% of total export value, indicating a highly concentrated market. Individual shares are: RELIANCE LIFE SCIENCES PRIVATE LIMITED (47.0%), BHARAT SERUMS AND VACCINES LIMITED (17.7%), RELIANCE LIFE SCIENCES PVT LTD (4.4%), LAZERHEAD LIFESCIENCES PRIVATE LIMITED (3.5%), VITANE PHARMACEUTICALS PRIVATE LIMITED (3.3%).
Top Immunoglobulin Exporters from India
Ranked by export value · 197 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | RELIANCE LIFE SCIENCES PRIVATE LIMITED HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVENGAMMA IV 5 GM NORMAL IMMUNOGLOBULIN FORINTRAVENOUS USE ##GLOBUCEL EP 5%SOLUTION 100ML VIAL.NOS | $84.6M | 27 | 47.0% |
| 2 | BHARAT SERUMS AND VACCINES LIMITED HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVENGAMMA IV 5 GM NORMAL IMMUNOGLOBULIN FORINTRAVENOUS USE ##RHOCLONE 300 MCG [ANTI RHO-D IMMUNOGLOBULIN INJECTION ] | $31.8M | 44 | 17.7% |
| 3 | RELIANCE LIFE SCIENCES PVT LTD HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVENGAMMA IV 5 GM NORMAL IMMUNOGLOBULIN FORINTRAVENOUS USE ##GLOBUCEL EP 5%SOLUTION 100ML VIAL.NOS | $7.9M | 9 | 4.4% |
| 4 | LAZERHEAD LIFESCIENCES PRIVATE LIMITED GLOBUCEL EP 5%SOLUTION 100ML VIAL.NOSLAZERGLOBGLOBUCEL EP 5% SOLUTION 100ML VIAL | $6.3M | 1 | 3.5% |
| 5 | VITANE PHARMACEUTICALS PRIVATE LIMITED GLOBUCEL EP 5%SOLUTION 100ML VIAL.NOSLAZERGLOBGLOBUCEL EP 5% SOLUTION 100ML VIAL | $5.9M | 1 | 3.3% |
| 6 | ICHOR BIOLOGICS PRIVATE LIMITED HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVENPROIVIG 5% - 100ML ,PACK:PROIVIG 5% - 100ML | $5.2M | 8 | 2.9% |
| 7 | CHANDRA BHAGAT PHARMA LIMITED GLOBUCEL EP 5%SOLUTION 100ML VIAL.NOSLAZERGLOBGLOBUCEL EP 5% SOLUTION 100ML VIAL | $5.1M | 2 | 2.8% |
| 8 | METPHARM BIOTECH PRIVATE LIMITED GLOBUCEL EP 5%SOLUTION 100ML VIAL.NOSLAZERGLOBGLOBUCEL EP 5% SOLUTION 100ML VIAL | $4.8M | 1 | 2.7% |
| 9 | VIRCHOW BIOTECH PRIVATE LIMITED HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVENGLOBUCEL EP 5%SOLUTION 100ML VIAL.NOSLAZERGLOB | $4.0M | 3 | 2.2% |
| 10 | GNH INDIA PHARMACEUTICALS LIMITED GAMMA IV 5 GM NORMAL IMMUNOGLOBULIN FORINTRAVENOUS USE ##GLOBUCEL EP 5%SOLUTION 100ML VIAL.NOSLAZERGLOB | $2.8M | 4 | 1.5% |
| 11 | VIRCHOW HEALTHCARE PRIVATE LIMITED HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVENGLOBUCEL EP 5%SOLUTION 100ML VIAL.NOSLAZERGLOB | $1.9M | 10 | 1.0% |
| 12 | MEDWISE OVERSEAS PRIVATE LIMITED | $1.6M | 3 | 0.9% |
| 13 | VANSH PHARMACEUTICALS AND DISTRIBUTOR HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVEN | $1.4M | 1 | 0.8% |
| 14 | VINS BIOPRODUCTS LIMITED GAMMA IV 5 GM NORMAL IMMUNOGLOBULIN FORINTRAVENOUS USE ##(HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVEGAMMA IV 5 GM [NORMAL IMMUNOGLOBULIN FORINTRAVENOUS USE ] | $1.4M | 6 | 0.8% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Immunoglobulin exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Reliance Life Sciences Private Limited | Not Listed | Yes | Yes | 2 | WHO-GMP and EU GMP certified; holds 2 ANDAs. |
| Bharat Serums and Vaccines Limited | Not Listed | Yes | Yes | 1 | WHO-GMP and EU GMP certified; holds 1 ANDA. |
| Virchow Biotech Private Limited | Not Listed | Yes | Yes | 1 | WHO-GMP and EU GMP certified; holds 1 ANDA. |
| Vins Bioproducts Limited | Not Listed | Yes | Yes | 1 | WHO-GMP and EU GMP certified; holds 1 ANDA. |
| Ichor Biologics Private Limited | Not Listed | Yes | Yes | 1 | WHO-GMP and EU GMP certified; holds 1 ANDA. |
| Metpharm Biotech Private Limited | Not Listed | Yes | Yes | 1 | WHO-GMP and EU GMP certified; holds 1 ANDA. |
| Chandra Bhagat Pharma Limited | Not Listed | Yes | Yes | 1 | WHO-GMP and EU GMP certified; holds 1 ANDA. |
| Vitane Pharmaceuticals Private Limited | Not Listed | Yes | Yes | 1 | WHO-GMP and EU GMP certified; holds 1 ANDA. |
| Lazerhead Lifesciences Private Limited | Not Listed | Yes | Yes | 1 | WHO-GMP and EU GMP certified; holds 1 ANDA. |
TransData Nexus reviewed the regulatory standing of 9 leading Immunoglobulin exporters from India. 0 hold US FDA facility approvals, 9 maintain WHO-GMP certification, and 9 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Immunoglobulin sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes approximately 40% of the nation's bulk drug production. The city hosts over 200 pharmaceutical companies, including major players like Dr. Reddy’s Laboratories, Aurobindo Pharma, and Bharat Biotech. The establishment of Hyderabad Pharma City, recognized as a National Investment and Manufacturing Zone (NIMZ), aims to further bolster the region's pharmaceutical manufacturing capabilities.
2Ahmedabad-Vadodara — Formulations Hub
Ahmedabad and Vadodara in Gujarat are prominent centers for pharmaceutical formulations. Gujarat accounts for 33% of India's drug manufacturing and 28% of drug exports, with Ahmedabad and Vadodara housing numerous pharmaceutical companies. Vadodara is home to Alembic Pharmaceuticals, a company specializing in formulations for therapeutic areas such as cardiology, dermatology, and infectious diseases.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for India's pharmaceutical industry. Mumbai, being a major port city, facilitates substantial pharmaceutical exports. The region hosts several pharmaceutical companies, leveraging its strategic location and infrastructure to access international markets efficiently.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh is recognized as a tax incentive zone, attracting numerous pharmaceutical manufacturers. The region offers fiscal benefits, including tax exemptions and subsidies, making it an attractive destination for pharmaceutical production.
5Sourcing Recommendations
- Diversify Supplier Base: While Reliance Life Sciences Private Limited dominates the immunoglobulin export market with a 47.0% share, consider engaging with other suppliers to mitigate dependency risks.
- Evaluate Manufacturing Clusters: Assess the capabilities of suppliers in Hyderabad for bulk drug production and those in Ahmedabad-Vadodara for formulations to align with specific sourcing needs.
- Leverage Export Infrastructure: Utilize the export facilities in the Mumbai-Thane-Raigad region to streamline international shipments and reduce logistical complexities.
- Consider Tax Incentives: Explore partnerships with manufacturers in the Baddi-Nalagarh zone to benefit from tax incentives, potentially reducing procurement costs.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Immunoglobulin exporters from India
Cohance Lifesciences Limited — Cohance Lifesciences acquires RA Chem Pharma Limited
Cohance Lifesciences Limited, incorporated on December 6, 2020, acquired RA Chem Pharma Limited on December 29, 2021. IMPACT: This acquisition is expected to enhance Cohance's production capabilities, potentially increasing immunoglobulin exports.
Impact: This acquisition is expected to enhance Cohance's production capabilities, potentially increasing immunoglobulin exports.
Bharat Serums and Vaccines Limited — Bharat Serums appoints new Additional Director
On December 14, 2023, Bharat Serums and Vaccines Limited appointed a new Additional Director, indicating a strategic move to strengthen its leadership team. IMPACT: This leadership enhancement may lead to improved operational strategies, potentially boosting immunoglobulin export performance.
Impact: This leadership enhancement may lead to improved operational strategies, potentially boosting immunoglobulin export performance.
Reliance Life Sciences Pvt Ltd — Reliance Life Sciences introduces Immunorel immunoglobulin
Reliance Life Sciences Pvt Ltd launched Immunorel, a human normal immunoglobulin solution, in August 2025. IMPACT: The introduction of Immunorel is anticipated to strengthen Reliance's position in the immunoglobulin market, potentially increasing export volumes.
Impact: The introduction of Immunorel is anticipated to strengthen Reliance's position in the immunoglobulin market, potentially increasing export volumes.
Common Questions — Immunoglobulin Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which immunoglobulin supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, RELIANCE LIFE SCIENCES PRIVATE LIMITED leads with 286 recorded shipments worth $84.6M. BHARAT SERUMS AND VACCINES LIMITED (329 shipments) and RELIANCE LIFE SCIENCES PVT LTD (17 shipments) are also established high-volume exporters.
Q How many immunoglobulin manufacturers are there in India?
India has 197 active immunoglobulin exporters with a combined export market of $180.0M across 1,841 shipments to 119 countries. The top 5 suppliers hold 75.8% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for immunoglobulin from India?
Average FOB unit price: $86.09 per unit, ranging from $0.00 to $880.70. Average shipment value: $97.8K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 197 verified Indian exporters of Immunoglobulin ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 1,841 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 119 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,841 Verified Shipments
197 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists